Mainz Biomed Statistics

Total Valuation

Mainz Biomed has a market cap or net worth of EUR 5.45 million. The enterprise value is 12.39 million.

Market Cap	5.45M
Enterprise Value	12.39M

Important Dates

The last earnings date was Friday, November 15, 2024.

Earnings Date	Nov 15, 2024
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+36.64%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	22.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.59
EV / Sales	14.20
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.68

Financial Position

The company has a current ratio of 0.24

Current Ratio	0.24
Quick Ratio	0.13
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.42
Interest Coverage	-19.50

Financial Efficiency

Return on equity (ROE) is -4,333.72% and return on invested capital (ROIC) is -154.40%.

Return on Equity (ROE)	-4,333.72%
Return on Assets (ROA)	-99.24%
Return on Capital (ROIC)	-154.40%
Revenue Per Employee	12,589
Profits Per Employee	-308,906
Employee Count	71
Asset Turnover	0.07
Inventory Turnover	0.83

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -80.91% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-80.91%
50-Day Moving Average	0.24
200-Day Moving Average	0.70
Relative Strength Index (RSI)	44.56
Average Volume (20 Days)	17,697

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.47

Income Statement

In the last 12 months, Mainz Biomed had revenue of EUR 856,026 and -21.01 million in losses. Loss per share was -1.05.

Revenue	856,026
Gross Profit	504,876
Operating Income	-20.57M
Pretax Income	-21.01M
Net Income	-21.01M
EBITDA	-20.15M
EBIT	-20.57M
Loss Per Share	-1.05

Full Income Statement

Balance Sheet

The company has 912,547 in cash and 7.72 million in debt, giving a net cash position of -6.81 million.

Cash & Cash Equivalents	912,547
Total Debt	7.72M
Net Cash	-6.81M
Net Cash Per Share	n/a
Equity (Book Value)	-3.86M
Book Value Per Share	-0.15
Working Capital	-7.12M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -18.02 million and capital expenditures -275,273, giving a free cash flow of -18.29 million.

Operating Cash Flow	-18.02M
Capital Expenditures	-275,273
Free Cash Flow	-18.29M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	58.98%
Operating Margin	-2,402.78%
Pretax Margin	-2,453.86%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-2,136.98%

Dividends & Yields

Mainz Biomed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-36.64%
Shareholder Yield	-36.64%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Mainz Biomed has an Altman Z-Score of -21.37. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-21.37
Piotroski F-Score	n/a